+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Prodrug"

Protein Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Protein Therapeutics - Global Strategic Business Report

  • Report
  • May 2025
  • 181 Pages
  • Global
From
From
Peptide Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Peptide Therapeutics - Global Strategic Business Report

  • Report
  • May 2025
  • 192 Pages
  • Global
From
Antibody Production - Global Strategic Business Report - Product Thumbnail Image

Antibody Production - Global Strategic Business Report

  • Report
  • May 2025
  • 103 Pages
  • Global
From
From
Monoclonal Antibodies - Global Strategic Business Report - Product Thumbnail Image

Monoclonal Antibodies - Global Strategic Business Report

  • Report
  • May 2025
  • 213 Pages
  • Global
From
From
Tangential Flow Filtration Market Report 2025 - Product Thumbnail Image

Tangential Flow Filtration Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
From
From
From
Monoclonal Antibodies Market Report and Forecast 2024-2032 - Product Thumbnail Image

Monoclonal Antibodies Market Report and Forecast 2024-2032

  • Report
  • May 2024
  • 160 Pages
  • Global
From
From
From
From
From
Loading Indicator

Prodrugs are a type of biotechnology that involves the modification of a drug molecule to improve its pharmacokinetic properties. This is done by making the drug more soluble, increasing its absorption, or making it more stable in the body. Prodrugs are designed to be more effective and safer than the original drug, and can be used to treat a variety of diseases. Prodrugs are used in a variety of therapeutic areas, including cancer, cardiovascular disease, and infectious diseases. They are also used to improve the delivery of drugs to specific tissues or organs, and to reduce the side effects of drugs. The prodrug market is growing rapidly, driven by the increasing demand for more effective and safer drugs. The market is expected to continue to grow in the coming years, as more companies develop and launch new prodrugs. Some companies in the prodrug market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more